A M Garvin
Overview
Explore the profile of A M Garvin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garvin A, Parker K, Haff L
Nat Biotechnol
. 2000 Jan;
18(1):95-7.
PMID: 10625400
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) is a powerful method to quickly and accurately determine the masses of peptides. Most genetic analyses, however, begin with PCR amplification of a...
2.
Hasse U, Tinguely M, Leibundgut E, Cajot J, Garvin A, Tobler A, et al.
J Natl Cancer Inst
. 1999 Sep;
91(18):1581-3.
PMID: 10491436
No abstract available.
3.
Hahn S, Garvin A, Di Naro E, Holzgreve W
Genet Test
. 1999 Aug;
2(4):351-5.
PMID: 10464616
The ability to analyze the genetic material of single cells by the PCR opens up new prospects for diagnostics. Because only two copies of the genetic template are available for...
4.
Garvin A
Eur J Hum Genet
. 1998 Oct;
6(3):226-34.
PMID: 9781026
The protein truncation test (PTT) is currently the fastest method in general use for detecting previously unidentified mutations in tumor suppressor genes. Greater than three kilobases of coding sequence can...
5.
Garvin A, Holzgreve W, Hahn S
Nucleic Acids Res
. 1998 Jul;
26(15):3468-72.
PMID: 9671806
Single cell PCR is a powerful method for determining the genetic properties of individual cells. In the instance of heterozygous loci, however, preferential amplification of one allele can lead to...
6.
Holzgreve W, Di Naro E, Garvin A, Troeger C, Hahn S
Croat Med J
. 1998 May;
39(2):115-20.
PMID: 9575265
The ability to use fetal cells enriched from the blood of pregnant women for prenatal diagnosis has been a long-sought goal for those pursuing a non-invasive alternative to current methods,...
7.
Garvin A, Scott R
J Med Genet
. 1998 Jan;
34(12):990-5.
PMID: 9429140
Eighty-six women fulfilling specific selection criteria were studied for germline mutations in two breast cancer susceptibility genes, BRCA1 and BRCA2, using the protein truncation test (PTT). Nine germline mutations were...
8.
Garvin A, Eppenberger U, Muller H, Eppenberger-Castori S, Scott R
Eur J Cancer
. 1997 Apr;
33(4):683-6.
PMID: 9274454
Inherited mutations in the BRCA1 gene are thought to account for approximately 5% of breast cancers in women under the age of 45 years. In order to determine whether mutations...
9.
Hamann U, Brauch H, Garvin A, Bastert G, Scott R
Genes Chromosomes Cancer
. 1997 Feb;
18(2):126-32.
PMID: 9115962
Women harboring BRCA1 germline mutations carry an 85% lifetime risk of developing breast cancer and a 63% risk of ovarian cancer. In this first systematic study of familial breast and/or...
10.
Garvin A, Spycher M, Haner M, Torhorst J, Muller H, Herrmann R, et al.
J Med Genet
. 1996 Sep;
33(9):721-5.
PMID: 8880569
Germline mutations in the BRCA1 gene have been associated with familial breast/ ovarian cancer in large families showing high penetrance of the disease. Little is known, however, about the contribution...